We are live on ! Find out more
VCYT icon

Veracyte

231 hedge funds and large institutions have $1.96B invested in Veracyte in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 91 increasing their positions, 82 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

13% more capital invested

Capital invested by funds: $1.74B → $1.96B (+$222M)

11% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 82

0% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 24

0% less funds holding

Funds holding: 232231 (-1)

2.66% less ownership

Funds ownership: 109.06%106.41% (-2.7%)

58% less call options, than puts

Call options by funds: $252K | Put options by funds: $593K

Holders
231
Holders Change
-1
Holders Change %
-0.43%
% of All Funds
3.62%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
24
Increased
91
Reduced
82
Closed
24
Calls
$252K
Puts
$593K
Net Calls
-$341K
Net Calls Change
-$791K

VCYT Hedge Fund Activity: Q2 2023 in Review

231 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2023, worth a combined $1.96B — up 13% from $1.74B a quarter earlier.

Fund positioning in VCYT was balanced in Q2 2023: 24 funds opened new positions, 24 closed out, 91 added to existing stakes and 82 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $27.1M. The largest seller was Citadel Advisors, cutting an estimated $22.7M.

  • 231 institutional investors held Veracyte (VCYT) as of Q2 2023, down from 232 in Q1 2023.
  • Funds reported $1.96B of Veracyte stock for Q2 2023, up 13% quarter-over-quarter.
  • 24 funds opened new Veracyte positions in Q2 2023 and 24 closed out, a net change of 0 holders.
  • The largest Veracyte buyer in Q2 2023 was Point72 Asset Management, an estimated $27.1M added.
  • The largest Veracyte seller in Q2 2023 was Citadel Advisors, an estimated $22.7M sold.

Based on aggregated 13F filings for Q2 2023.